| Literature DB >> 28587323 |
Jing-Jian Wang1, Shu-Jie Fan2, Long-Long Wang1, Yan-Zhong Gao1, Xiao-Juan Liu3.
Abstract
A variety of imaging methods can be used in the diagnosis of atherosclerotic plaques. In the present study, we investigated the morphology and composition of atherosclerotic plaque associated with ischemic cerebral infarction by comparing gemstone spectral computed tomography (GSCT) and traditional multi-slice CT (MSCT). In total, 200 patients were enrolled and divided into the experimental group (n=100), which underwent GSCT, and the control group (n=100), which underwent MSCT. All the cases were followed up to observe disease outcomes in patients with different atherosclerotic plaque types, and adverse events in carotid artery stenosis or cerebral infarction were recorded. Compared with traditional MSCT, sensitivity (93.2%), specificity (84.5%), and accuracy (91.0%) of GSCT were significantly higher. We found a correlation between vulnerable plaque of carotid atherosclerotic plaque and the occurrence of cerebral infarction. These results suggest the advantages of GSCT in analyzing atherosclerotic plaque and predicting the risk of ischemic cerebral infarction.Entities:
Keywords: atherosclerosis; computed tomographic angiography; gemstone spectral computed tomography
Year: 2017 PMID: 28587323 PMCID: PMC5450728 DOI: 10.3892/etm.2017.4342
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Clinical questionnaire for patients with carotid plaque.
| Age | ___Years old | |
|---|---|---|
| Gender | □ Male | □ Female |
| Marital status | □ Married | □ Unmarried |
| Nationality | □ Han | □ Others (please specify) |
| Occupation | (01) Students, (02) teachers, (03) conservation nanny, (04) food (05), business services, (06) medical personnel, (07) workers, (08) migrant workers, (09) farmers, (10) herders, (11) fishermen, (12) cadres, (13) retired, (14) unemployed, (15) other ___________ (please specify), (16) unknown | |
| Degree of education | (1) Illiteracy, (2) primary school, (3) junior high school, (4) high school, (5) University and above, (6) unknown | |
| Important past history | □ No | □ Yes (Detailed description_________________) |
| Allergic history | □ No | □ Yes (Detailed description_________________) |
| Smoking history | □ No | □ Yes (Detailed description_________________) |
| Drinking history | □ No | □ Yes (Detailed description_________________) |
| Height | |_|_|.|_| cm | |
| Weight | |_|_|_|.|_| kg | |
| BMI | |_|_|_|.|_| kg/m2 | |
| Subcutaneous fat thickness | |_|_|.|_| cm | |
| Main clinical manifestations | □ No | □ Yes (Detailed description_________________) |
| Ultrasonic examination | □ No | □ Yes (Detailed description_________________) |
| Pathological examination | □ Stable plaque | □ Vulnerable plaque (Detailed description_________________) |
| Site: 1. Initial part of common carotid artery, 2. Trunk of common carotid artery, 3. Bifurcation of common carotid artery (including the initial part of the internal carotid artery), 4. Trunk of internal carotid artery, 5. Internal carotid siphon, 6. Bilateral vertebral artery (intracranial and extra cranial segment | □ Single | □ Multiple (Detailed description_________________) |
| Hyperlipidemia | □ Yes | □ No (Detailed description_________________) |
| Coronary heart disease | □ Yes | □ No (Detailed description_________________) |
| Radiation exposure history | □ Yes | □ No (Detailed description_________________) |
| Diabetes | □ Yes | □ No (Detailed description_________________) |
| Cerebral infarction | □ Yes | □ No (Detailed description_________________) |
| Transient ischemic attack | □ Yes | □ No (Detailed description_________________) |
| Chronic cerebral circulatory insufficiency | □ Yes | □ No (Detailed description_________________) |
| Posterior circulation ischemia | □ Yes | □ No (Detailed description_________________) |
Clinical data of patients in the experimental and control groups.
| Group | No. of cases (male/female) | Age (years) | SBP (mmHg) | DBP (mmHg) | BMI (kg/m2) | AST (U/l) | ALT (U/l) |
|---|---|---|---|---|---|---|---|
| Control | 132 (57/75) | 3.65±0.87 | 118.5±30.5 | 70.4±22.8 | 19.7±2.4 | 17.2±2.1 | 12.7±3.6 |
| Experimental | 132 (72/60) | 3.27±1.24 | 102.4±23.7 | 67.4±34.7 | 23.6±1.8 | 16.5±2.4 | 3.2±4.9 |
| T-value | – | 0.68 | 0.17 | 0.45 | 9.32 | 0.78 | 0.44 |
| P-value | – | 0.37 | 0.21 | 0.34 | 0.002 | 0.27 | 0.38 |
| Group | GGT (U/l) | FPG (mmol/l) | HbA1C (%) | TG (mmol/l) | HDL-C (mmol/l) | LDL-C (mmol/l) | |
| Control | 18.6±2.2 | 4.37±0.85 | 4.70±0.43 | 185.4±20.6 | 67.5±13.5 | 98.5±10.2 | |
| Experimental | 17.3±3.6 | 8.24±3.36 | 7.82±1.03 | 177.3±21.2 | 68.4±11.8 | 102.3±21.6 | |
| T-value | 0.67 | 9.79 | 0.56 | 0.75 | 0.52 | 0.63 | |
| P-value | 0.43 | 0.002 | 0.28 | 0.92 | 0.48 | 0.38 | |
SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, γ-glutamyltransferase; FPG, fasting plasma glucose; HbA1C, glycosylated hemoglobin; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
Analysis of general clinical history of the patients in the group (%).
| Parameters | Experimental | Control | T-value | P-value |
|---|---|---|---|---|
| No. of cases, n | 100 | 100 | – | – |
| Age (years) | 57.3±10.2 | 61.3±12.4 | 1.24 | 0.43 |
| Male, n (%) | 48 (0.48) | 64 (0.64) | 0.28 | 0.75 |
| Hypertension, n (%) | 38 (0.38) | 31 (0.31) | 0.24 | 0.81 |
| Diabetes, n (%) | 42 (0.42) | 45 (0.45) | 0.43 | 0.33 |
| Coronary heart disease, n (%) | 20 (0.20) | 26 (0.26) | 0.83 | 0.78 |
| Hyperlipidemia, n (%) | 27 (0.27) | 21 (0.21) | 0.28 | 0.24 |
| Smoking, n (%) | 22 (0.22) | 23 (0.23) | 1.09 | 0.43 |
| Transient ischemic attack, n (%) | 7 (0.07) | 8 (0.08) | 1.23 | 0.56 |
| Chronic cerebral circulatory insufficiency, n (%) | 12 (0.12) | 9 (0.09) | 2.19 | 0.71 |
| Cerebral infarction, n (%) | 4 (0.04) | 3 (0.03) | 2.24 | 0.83 |
| Posterior circulation ischemia, n (%) | 4 (0.04) | 2 (0.02) | 2.13 | 0.98 |
| Intima layer thickness (mm) | 0.98±1.02 | 0.89±1.17 | 0.32 | 0.24 |
| Three or more carotid plaques, n (%) | 8 (0.08) | 9 (0.09) | 0.04 | 0.45 |
Figure 1.Patient examined using GSCT. (A) Cervical arteries and stenosis in supine position. (B) Detection of carotid artery plaque formation. (C) Left common carotid artery on the left side. (D) Right common carotid artery. GSCT, gemstone spectral computed tomography.
Figure 2.Vulnerable plaques were better detected by spectral CT, whereas more stable and non-atherosclerotic plaques were more frequently detected by MSCT. CT, computed tomography; MSCT, multi-slice computed tomography.
Detection rate of vulnerable and stable plaques in the two groups.
| Group | No. of cases | Vulnerable plaque | Stable plaque | Non-atherosclerotic plaque |
|---|---|---|---|---|
| Control | 100 | 74 | 10 | 16 |
| Experimental | 100 | 48 | 22 | 30 |
| χ2 value | – | 21.7 | ||
| P-value | – | 0.007 |
Figure 3.(A) Arrow indicates the carotid plaque detected and the ROI. (B) The system automatically produced the energy spectrum curve, enabling determination of the characteristics of the carotid atherosclerotic plaque.
Figure 4.(A) Arrow indicates the carotid plaque detected and the ROI. (B) The system automatically produced the energy spectrum curve, enabling identification of the carotid atherosclerotic plaque as lipid plaque.
Correlation analysis of multiple risk factors of cerebral infarction and cerebral infarction (r).
| Index | Gender | Age | Stable plaque | Vulnerable plaque | SBP (mmHg) | DBP (mmHg) | AST (U/l) | ALT (U/l) | GGT (U/l) | FPG (mmol/l) | BMI (kg/m2) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cerebral infarction | |||||||||||
| r | 0.02 | 0.35 | 0.17 | 1.03 | 0.16 | 0.28 | 0.24 | 0.15 | 0.06 | 0.38 | 0.14 |
| P-value | 0.88 | 0.42 | 0.03 | 0.01 | 0.13 | 0.24 | 0.93 | 0.47 | 0.01 | 0.28 | 0.02 |
SBP, systolic blood pressure; DBP, diastolic blood pressure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, γ-glutamyltransferase; FPG, fasting plasma glucose; BMI, body mass index.
Correlation analysis.
| 95% CI | |||||||
|---|---|---|---|---|---|---|---|
| Variables | β | SE | β | T-value | P-value | Upper limit | Lower limit |
| Vulnerable plaque | 0.681 | 0.10 | 0.642 | 0.652 | 0.02 | 0.39 | 0.78 |
| Stable plaque | 0.372 | 0.02 | 0.483 | 0.328 | 0.25 | 0.27 | 0.58 |
| BMI | 0.768 | 0.08 | 0.871 | 0.981 | 0.32 | 0.61 | 0.92 |
BMI, body mass index; CI, confidence interval.
Comparison of accuracy, sensitivity, specificity, positive predictive value and negative predictive value (%).
| Variables | Sensitivity (%) | Specificity (%) | Positive predictive value (%) | Negative predictive value (%) | Accuracy (%) |
|---|---|---|---|---|---|
| GSCT | 93.2 | 84.5 | 94.5 | 81.5 | 91.0 |
| MSCT | 62.5 | 61.5 | 67.7 | 84.2 | 74.0 |
| T-value | 9.27 | 7.88 | 1.39 | 1.57 | 8.17 |
| P-value | 0.002 | 0.017 | 0.132 | 0.148 | 0.011 |
GSCT, gemstone spectral computed tomography; MSCT, traditional multi-slice computed tomography.
Figure 5.ROC curves of GSCT, MSCT, and gold standard DSA for the diagnosis of carotid plaque. GSCT, gemstone spectral computed tomography; MSCT, multi-slice computed tomography.